Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
A cross-sectional observational study to describe treatment management of patients with Major Depressive Disorder (MDD) and inadequate response to antidepressants in Greece
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of MDD as per DSM-IV
Patients with an inadequate disease control during antidepressant therapy
Patients who already receive add-on therapy and have completed 4-5 weeks of treatment at the time of their enrolment in the study.
You may not be if
Patients fulfilling criteria for diagnosis of any other psychiatric condition (except for MDD), as per DSM-IV Axis I,
Concomitant organic mental disorder or mental retardation Substance abuse or dependence (with the exception of nicotine dependence), as defined by DSM-IV criteria Participation in another study
Clareo Health | Description of Treatment Management of Patients With Major Depressive Disorder and Inadequate Response
